These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9121184)
1. Malignant melanoma: prognostic indicators. Ahmed I Mayo Clin Proc; 1997 Apr; 72(4):356-61. PubMed ID: 9121184 [TBL] [Abstract][Full Text] [Related]
2. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800 [TBL] [Abstract][Full Text] [Related]
3. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma? Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882 [TBL] [Abstract][Full Text] [Related]
4. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408 [TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma in the lower extremity. A comprehensive overview. Hutchinson BL Clin Podiatr Med Surg; 1986 Jul; 3(3):533-50. PubMed ID: 2943398 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of clinicopathologic variables and DNA ploidy in stage I cutaneous malignant melanoma. Tralongo V; Daniele E; Leonardi V; Rodolico V Oncol Rep; 1998; 5(5):1095-8. PubMed ID: 9683815 [TBL] [Abstract][Full Text] [Related]
7. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas. Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129 [TBL] [Abstract][Full Text] [Related]
8. The importance of anatomic site in prognosis in patients with cutaneous melanoma. Wong JH; Wanek L; Chang LJ; Goradia T; Morton DL Arch Surg; 1991 Apr; 126(4):486-9. PubMed ID: 2009064 [TBL] [Abstract][Full Text] [Related]
9. Prognosis and staging in melanoma. Garrison M; Nathanson L Semin Oncol; 1996 Dec; 23(6):725-33. PubMed ID: 8970594 [TBL] [Abstract][Full Text] [Related]
10. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123 [TBL] [Abstract][Full Text] [Related]
11. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251 [TBL] [Abstract][Full Text] [Related]
12. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496 [TBL] [Abstract][Full Text] [Related]
13. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651 [TBL] [Abstract][Full Text] [Related]
14. Current staging and prognostic factors in melanoma. Bartlett EK; Karakousis GC Surg Oncol Clin N Am; 2015 Apr; 24(2):215-27. PubMed ID: 25769707 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in head and neck melanoma. Effect of lesion location. Wanebo HJ; Cooper PH; Young DV; Harpole DH; Kaiser DL Cancer; 1988 Aug; 62(4):831-7. PubMed ID: 3395962 [TBL] [Abstract][Full Text] [Related]
18. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I]. Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging. Pilch H; Günzel S; Schäffer U; Tanner B; Heine M Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma. Law MM; Wong JH Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]